Stephanie Stahnke

Prof. Stephanie Stahnke

Technische Universität Braunschweig, Braunschweig, Lower Saxony, Germany
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2015 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
LALisa Andzinski
Lisa Andzinski
NKNadine Kasnitz
Nadine Kasnitz
Stephanie StahnkeStephanie Stahnke
Stephanie Stahnke
CWChing‐Fang Wu
Ching‐Fang Wu
MGMarcus Gereke
Marcus Gereke
Jadwiga JablonskaJadwiga Jablonska
Jadwiga Jablonska
The importance of tumor associated neutrophils (TANs) in cancer development is in the meantime well established. Numerous of clinical data document the adverse prognostic effects of neutrophil infiltration in solid tumors. However, certain tumor therapies need functional neutrophils to be effective, suggesting altered neutrophil polarization associated with different outcomes for cancer patients. Therefore, modulation of neutrophilic phenotypes represents a potent therapeutic option, but factors mediating neutrophil polarization are still poorly defined. In this manuscript we provide evidence that type I IFNs alter neutrophilic phenotype into anti‐tumor, both in mice and human. In the absence of IFN‐β, pro‐tumor properties, such as reduced tumor cytotoxicity with low neutrophil extracellular traps (NETs) expression, low ICAM1 and TNF‐α expression, dominated neutrophil phenotypes in primary lesion and premetastatic lung. Interestingly, such neutrophils have significantly prolonged life‐span. Notably, interferon therapy in mice altered TAN polarization towards anti‐tumor N1. Similar changes in neutrophil activation could be observed in melanoma patients undergoing type I IFN therapy. Altogether, these data highlight the therapeutic potential of interferons, suggesting optimization of its clinical use as potent anti‐tumor agent.

3 July 2020 in Science Immunology
Verified
Journal Article
Closed access
ESElisabeth Salzer
Elisabeth Salzer
SZSamaneh Zoghi
Samaneh Zoghi
MKMáté G. Kiss
Máté G. Kiss
FKFrieda Kage
Frieda Kage
CRChristina Rashkova
Christina Rashkova
KBKaan Boztug
Kaan Boztug
HEM1 deficiency causes heritable autoimmunity and immunodeficiency.

1 May 2021 in Current Biology
Verified
Journal Article
Closed access
Stephanie StahnkeStephanie Stahnke
Stephanie Stahnke
HDHermann Döring
Hermann Döring
CKCharly Kusch
Charly Kusch
DGDavid J.J. de Gorter
David J.J. de Gorter
SDSebastian Dütting
Sebastian Dütting
Theresia E.B. StradalTheresia E.B. Stradal
Theresia E.B. Stradal

16 May 2022 in Cells
Verified
Journal Article
Open access
PDF file
MKMarco Kirchenwitz
Marco Kirchenwitz
Stephanie StahnkeStephanie Stahnke
Stephanie Stahnke
SPSilvia Prettin
Silvia Prettin
MBMalgorzata Borowiak
Malgorzata Borowiak
LMLaura Menke
Laura Menke
ASAnika Steffen
Anika Steffen
SMER28 (Small molecule enhancer of Rapamycin 28) is an autophagy-inducing compound functioning by a hitherto unknown mechanism. Here, we confirm its autophagy-inducing effect by assessing classical autophagy-related parameters. Interestingly, we also discovered several additional effects of SMER28, including growth retardation and reduced G1 to S phase progression. Most strikingly, SMER28 treatment led to a complete arrest of receptor tyrosine kinase signaling, and, consequently, growth factor-induced cell scattering and dorsal ruffle formation. This coincided with a dramatic reduction in phosphorylation patterns of PI3K downstream effectors. Consistently, SMER28 directly inhibited PI3Kδ and to a lesser extent p110γ. The biological relevance of our observations was underscored by SMER28 interfering with InlB-mediated host cell entry of Listeria monocytogenes, which requires signaling through the prominent receptor tyrosine kinase c-Met. This effect was signaling-specific, since entry of unrelated, gram-negative Salmonella Typhimurium was not inhibited. Lastly, in B cell lymphoma cells, which predominantly depend on tonic signaling through PI3Kδ, apoptosis upon SMER28 treatment is profound in comparison to non-hematopoietic cells. This indicates SMER28 as a possible drug candidate for the treatment of diseases that derive from aberrant PI3Kδ activity.

25 March 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
Stephanie StahnkeStephanie Stahnke
Stephanie Stahnke
HDHermann Döring
Hermann Döring
CKCharly Kusch
Charly Kusch
DGDavid J.J. de Gorter
David J.J. de Gorter
SDSebastian Dütting
Sebastian Dütting
Theresia E.B. StradalTheresia E.B. Stradal
Theresia E.B. Stradal
The hematopoietic-specific protein 1 (Hem1) comprises an essential subunit of the WAVE Regulatory Complex (WRC) in immune cells. WRC has a fundamental role in Arp2/3 complex activation and the protrusion of branched actin networks in motile cells. Hem1 deficiency leads to suppression of the entire WRC in immune cells. Defective WRC function in macrophages results in loss of lamellipodia and migration defects. Moreover, phagocytosis, commonly accompanied by lamellipodium protrusion during cup formation, is altered in Hem1 null cells concerning frequency and efficacy. When analyzing cell spreading, adhesion and podosome formation, we found that Hem1 null cells are capable, in principle, of podosome formation and consequently, do not show any quantitative differences in extracellular matrix degradation. Their adhesive behavior, however, was significantly altered. Specifically, adhesion as well as de-adhesion of Hem1 null cells was strongly compromised, likely contributing to the observed reduced efficiency of phagocytosis. In line with this, phosphorylation of the prominent adhesion component paxillin was diminished. Non-hematopoietic somatic cells disrupted in expression for both Hem1 and its ubiquitous orthologue Nck-associated protein 1 (Nap1) or the essential WRC components Sra-1/PIR121 did not only confirm defective paxillin phosphorylation, but also revealed that paxillin turnover in focal adhesions is accelerated in the absence of WRC. Finally, adhesion assays using platelets lacking functional WRC as model system unmasked radically decreased αIIbβ3 integrin activation. Our results thus demonstrate that WRC-driven actin networks impact on integrin-dependent processes controlling formation and dismantling of different types of cell-substratum adhesion. One sentence summary: Interference of Hem1 function in mice and cells uncovers a hitherto unrecognized role in integrin-mediated cell adhesion that is crucial for macrophage function and connects to recently discovered immunodeficiencies in patients carrying Hem1 mutations.

18 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
FKFrieda Kage
Frieda Kage
HDHermann Döring
Hermann Döring
MMMagdalena Mietkowska
Magdalena Mietkowska
MSMatthias Schaks
Matthias Schaks
FGFranziska Grüner
Franziska Grüner
Klemens RottnerKlemens Rottner
Klemens Rottner
Summary: Cell migration frequently involves the formation of lamellipodia induced by Rac GTPases mediating activation of WAVE Regulatory Complex (WRC) driving Arp2/3 complex-dependent actin assembly. Previous genome editing studies solidified the view of an essential, linear pathway employing aforementioned components. Using disruption of the WRC subunit Nap1 and its paralogue Hem1 followed by serum and growth factor stimulation or expression of active GTPases now revealed a pathway to formation of Arp2/3 complex-dependent, lamellipodia-like structures (LLS) that require both Rac and Cdc42, but not WRC. These observations were independent of WRC subunit eliminated and coincided with the lack of recruitment of Ena/VASP family actin polymerases. Moreover, aside from the latter, induced LLS contained all common lamellipodial regulators tested, including cortactin, the Ena/VASP ligand lamellipodin or FMNL subfamily formins. Our studies thus establish the existence of a signaling axis to Arp2/3 complex-dependent actin remodeling at the cell periphery operating without WRC and Ena/VASP.